|
|
Volumn 53, Issue 3, 2012, Pages 506-507
|
|
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma
a
b
b
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
BRENTUXIMAB VEDOTIN;
CARMUSTINE;
CD30 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
FLUORODEOXYGLUCOSE F 18;
LACTATE DEHYDROGENASE;
MELPHALAN;
PREDNISONE;
VINCRISTINE;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RECURRENCE;
CASE REPORT;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DIARRHEA;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
FATIGUE;
FEVER;
HUMAN;
HYPOPHOSPHATEMIA;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LARGE CELL LYMPHOMA;
LEG PAIN;
LETTER;
LYMPH NODE BIOPSY;
LYMPHADENOPATHY;
MALE;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
NIGHT SWEAT;
OUTCOME ASSESSMENT;
PAIN;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
RELAPSE;
REMISSION;
SIDE EFFECT;
SWELLING;
TREATMENT RESPONSE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARMUSTINE;
CLINICAL TRIALS, PHASE I AS TOPIC;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
HUMANS;
IMMUNOCONJUGATES;
LYMPHOMA, LARGE-CELL, ANAPLASTIC;
MAINTENANCE CHEMOTHERAPY;
MALE;
MELPHALAN;
PREDNISONE;
REMISSION INDUCTION;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
VINCRISTINE;
|
|
EID: 84857587738
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.3109/10428194.2011.614706 Document Type: Letter |
|
Times cited : (12)
|
|
References (3)
|
